156 related articles for article (PubMed ID: 8483974)
1. Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia.
Davidson M; Kahn RS; Stern RG; Hirschowitz J; Apter S; Knott P; Davis KL
Psychiatry Res; 1993 Feb; 46(2):151-63. PubMed ID: 8483974
[TBL] [Abstract][Full Text] [Related]
2. Clozapine response and plasma catecholamines and their metabolites.
Green AI; Alam MY; Sobieraj JT; Pappalardo KM; Waternaux C; Salzman C; Schatzberg AF; Schildkraut JJ
Psychiatry Res; 1993 Feb; 46(2):139-49. PubMed ID: 8483973
[TBL] [Abstract][Full Text] [Related]
3. Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine.
Sumiyoshi T; Hasegawa M; Jayathilake K; Meltzer HY
Psychiatry Res; 1997 Mar; 69(2-3):113-21. PubMed ID: 9109179
[TBL] [Abstract][Full Text] [Related]
4. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
Davidson M; Kahn RS; Knott P; Kaminsky R; Cooper M; DuMont K; Apter S; Davis KL
Arch Gen Psychiatry; 1991 Oct; 48(10):910-3. PubMed ID: 1929760
[TBL] [Abstract][Full Text] [Related]
5. Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia.
Sumiyoshi T; Roy A; Kim CH; Jayathilake K; Lee MA; Sumiyoshi C; Meltzer HY
Psychopharmacology (Berl); 2004 Dec; 177(1-2):79-83. PubMed ID: 15179543
[TBL] [Abstract][Full Text] [Related]
6. Plasma homovanillic acid in untreated schizophrenia--relationship with symptomatology and sex.
Zhang ZJ; Peet M; Ramchand CN; Shah S; Reynolds GP
J Psychiatr Res; 2001; 35(1):23-8. PubMed ID: 11287053
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol response and plasma catecholamines and their metabolites.
Green AI; Alam MY; Boshes RA; Waternaux C; Pappalardo KM; Fitzgibbon ME; Tsuang MT; Schildkraut JJ
Schizophr Res; 1993 Jun; 10(1):33-7. PubMed ID: 8369230
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine.
Hatzimanolis J; Lykouras L; Markianos M; Oulis P
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1077-85. PubMed ID: 9829289
[TBL] [Abstract][Full Text] [Related]
9. Plasma homovanillic acid and treatment response in a large group of schizophrenic patients.
Chang WH; Hwu HG; Chen TY; Lin SK; Lung FW; Chen H; Lin WL; Hu WH; Lin HN; Chien CP
Schizophr Res; 1993 Oct; 10(3):259-65. PubMed ID: 8260444
[TBL] [Abstract][Full Text] [Related]
10. Measurement of plasma homovanillic acid concentrations in schizophrenic patients.
Kaminski R; Powchick P; Warne PA; Goldstein M; McQueeney RT; Davidson M
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):271-87. PubMed ID: 2193315
[TBL] [Abstract][Full Text] [Related]
11. Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptoms.
Khan RS; Amin F; Powchik P; Knott P; Goldstein M; Apter S; Kerman B; Jaff S; Davidson M
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):879-84. PubMed ID: 1980541
[TBL] [Abstract][Full Text] [Related]
12. Plasma homovanillic acid in schizophrenics: supportive evidence for the two-subtype hypothesis.
Chen TY; Lee CF; Lung FW; Lee TC; Lin WL; Hu WH; Yeh EK; Chang WH
Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):584-8. PubMed ID: 2571672
[TBL] [Abstract][Full Text] [Related]
13. Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.
Koreen AR; Lieberman J; Alvir J; Mayerhoff D; Loebel A; Chakos M; Amin F; Cooper T
Arch Gen Psychiatry; 1994 Feb; 51(2):132-8. PubMed ID: 7905259
[TBL] [Abstract][Full Text] [Related]
14. Improvement of schizophrenic symptoms and changes in plasma HVA concentrations, plasma anti-D2 and anti-5-HT2 receptor activities with clozapine.
Yamada K; Kanba S; Wang ZC; Suzuki E; Fang YY; Yan HG; Nibuya M; Yagi G; Asai M
Psychiatry Clin Neurosci; 1996 Oct; 50(5):291-4. PubMed ID: 9201793
[TBL] [Abstract][Full Text] [Related]
15. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
[TBL] [Abstract][Full Text] [Related]
16. Plasma HVA in psychiatric patients: longitudinal studies.
Javaid JI; Sharma RP; Janicak PG; Davis JM
Psychopharmacol Bull; 1990; 26(3):361-5. PubMed ID: 2274637
[TBL] [Abstract][Full Text] [Related]
17. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
Brown AS; Gewirtz G; Harkavy-Friedman J; Cooper T; Brébion G; Amador XF; Malaspina D; Gorman JM
Neuropsychopharmacology; 1997 Nov; 17(5):317-25. PubMed ID: 9348547
[TBL] [Abstract][Full Text] [Related]
18. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
[TBL] [Abstract][Full Text] [Related]
19. The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy.
Breier A; Buchanan RW; Waltrip RW; Listwak S; Holmes C; Goldstein DS
Neuropsychopharmacology; 1994 Feb; 10(1):1-7. PubMed ID: 8179790
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence of demographic variables and the inpatient drug-free period.
Sharma RP; Javaid JI; Davis JM; Janicak PG
Biol Psychiatry; 1998 Sep; 44(6):488-92. PubMed ID: 9777181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
